Summit Therapeutics Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
36,391,063
Value ($000)
689,975
Weight
4.0%
2022 Q4 - 2026 Q1 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).